HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Multi-infarct dementia — Clinical Guidelines

Overview

Multi-infarct dementia results from multiple small strokes caused by arteriosclerosis, leading to cognitive decline and functional impairment due to cumulative brain damage rather than continuous ischemia 17.

Diagnosis

Clinical history of recurrent strokes or transient ischemic attacks (TIAs) 17.

Neurological examination revealing cognitive deficits, gait disturbances, or other focal deficits 17.

Neuroimaging (CT or MRI) showing multiple lacunar infarcts or white matter changes 17.

Exclusion of other causes of dementia through cognitive testing and laboratory investigations 17.

Management

Primary Prevention: Management of cardiovascular risk factors including hypertension, hyperlipidemia, and diabetes 17.

Secondary Prevention: Antiplatelet therapy (e.g., aspirin) to reduce the risk of further strokes 17.

Supportive Care: Cognitive rehabilitation, occupational therapy, and management of behavioral symptoms 17.

Avoid Unproven Treatments: Use of cerebral vasodilators and metabolic "activators" lacks scientific basis 17.

Special Populations

Elderly: Increased prevalence and complexity of comorbidities; focus on comprehensive stroke prevention strategies 17.

Comorbidities: Management of coexisting cardiovascular diseases is crucial for preventing further infarcts 17.

Key Recommendations

Focus on prevention and management of stroke risk factors to mitigate further cerebral damage (Evidence: Strong 17).

Utilize antiplatelet agents for secondary prevention to reduce the incidence of recurrent strokes (Evidence: Strong 17).

Avoid treatments aimed at enhancing cerebral blood flow or metabolism without robust evidence (Evidence: Expert opinion 17).

References

1 Russo FP, Murad SD, Pillai AA, Shingina A, Donahoe L, Mrzljak A et al.. Combined liver with other solid organ transplants: Promises, pitfalls and ethical dilemmas. Journal of hepatology 2025. link 2 Wang Y, Wang Y, Yang F, Chen J, Geng X, Sun Q et al.. Cytokine Storm Induction Linked to Multi-Organ Failure in Fatal Jellyfish Stings. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025. link 3 Engen RM, Lemoine CP. Evaluation and post-transplant management of children after multi-organ-with-kidney transplantation. Pediatric nephrology (Berlin, Germany) 2024. link 4 Osman AF, Prasad RM, Marein S, O'Brien C. Multi-organ dysfunction as a presentation of calcium channel blocker intoxication. BMJ case reports 2022. link 5 Kulenovic A, Lagumdzija-Kulenovic A. Using PM-TOM for the Minimization of Adverse Drug and Gene Interactions in Therapies for Common Multi-Diseases. Studies in health technology and informatics 2020. link 6 Pérez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R et al.. Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure. Biochimica et biophysica acta. Molecular basis of disease 2019. link 7 Díaz Gómez C, López Amor L, García Prieto E, Escudero Augusto D. Magnesium poisoning, multi-organ failure and ischemic colitis secondary to chronic ingestion of a parapharmacy product. Revista espanola de enfermedades digestivas 2018. link 8 Hoffmann F, Allers K. Age and sex differences in hospitalisation of nursing home residents: a systematic review. BMJ open 2016. link 9 Cullis PS, Watson D, Cameron A, McKee RF. Dipyridamole and paracetamol overdose resulting in multi-organ failure. Scottish medical journal 2013. link 10 Mahmoodpoor A, Soleimanpour H, Hamishehkar H. Multi organ failure following intravenous gasoline for suicide: a case report. Acta medica Iranica 2012. link 11 Gould A, Ho KM, Dobb G. Risk factors and outcomes of high-dependency patients requiring intensive care unit admission: a nested case-control study. Anaesthesia and intensive care 2010. link 12 Mao Q, Li YS, Li JS. The current status of multivisceral transplantation. Hepatobiliary & pancreatic diseases international : HBPD INT 2009. link 13 Wudel LJ, Allos TM, Washington MK, Sheller JR, Chapman WC. Multi-organ inflammation after hepatic cryoablation in BALB/c mice. The Journal of surgical research 2003. link00088-x) 14 Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J et al.. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. The journal of gene medicine 2003. link 15 Gnarpe J, Gnarpe H, Nissen K, Haldar K, Nääs J. Chlamydia pneumoniae infection associated with multi-organ failure and fatal outcome in a previously healthy patient. Scandinavian journal of infectious diseases 1998. link 16 Valenzuela P, Paris E, Oberpauer B, Rios JC, Concha F. Overdose of colchicine in a three-year-old child. Veterinary and human toxicology 1995. link 17 Hachinski V. Multi-infarct dementia. Neurologic clinics 1983. link

Multi-infarct dementia